Business Insights: Page 2

Lab manager, employees, sales reps on hook in $7.2M whistleblower fraud case

By LabPulse.com staff writers

Settlements reveal the consequences of clinical laboratory tests used for nonmedical purposes.

September 27, 2024

Ibex survey indicates some comfort with AI in cancer diagnostics

By LabPulse.com staff writers

A recent survey reports that more than 50% of U.S. adults have received an incorrect medical test result for themselves or a loved one. Additionally, 60% would trust artificial intelligence (AI) supporting medical diagnoses.

September 25, 2024

Angle, NuProbe sign licensing agreement on NGS panel

By LabPulse.com staff writers

Liquid biopsy firm Angle has signed a licensing agreement with NuProbe to use NuProbe's next-generation sequencing (NGS) panel in its pan-cancer molecular sequencing assay.

September 23, 2024

CDC lab division restructure bolsters quality, technical roles

By LabPulse.com staff writers

The U.S. Centers for Disease Control and Prevention's (CDC) Office of Laboratory Science and Safety has been retitled, plus other updates were announced.

September 23, 2024

Bio-Rad, Sysmex America partner for QC in hemostasis systems

By LabPulse.com staff writers

Bio-Rad Laboratories and diagnostic test firm Sysmex America have formed a partnership in which Bio-Rad's Unity Next Peer QC software is offered with the Sysmex CA-Series and CS-Series hemostasis systems for coagulation testing.

September 24, 2024

PictorLabs raises $30M in series B financing round

By LabPulse.com staff writers

Digital pathology software firm PictorLabs has successfully completed its $30 million series B funding round.

September 19, 2024

Humana, UnitedHealthcare change Z-code requirements for molecular diagnostic test claims

By LabPulse.com staff writers

Among the tests in focus are certain RNA- and DNA-based tests.

September 19, 2024

Eurofins Genomics US opens new manufacturing facility

By LabPulse.com staff writers

Eurofins Genomics US announced the opening of its new U.S. oligonucleotide manufacturing facility.

September 20, 2024

Scancell, PharmaJet sign agreement for melanoma vaccine delivery system

By LabPulse.com staff writers

Clinical-stage biopharmaceutical company Scancell has signed a strategic partnership agreement with PharmaJet for the supply of PharmaJet's needle-free Stratis delivery system for the delivery of Scancell's advanced melanoma vaccine.

September 18, 2024

Independent directors of 23andMe resign

By LabPulse.com staff writers

The seven independent directors of genetic testing company 23andMe resigned on September 17, saying they had not yet received a satisfactory take-private proposal from CEO Anne Wojcicki five months after she made the offer.

September 18, 2024

CDC adds commercial lab contracts for infectious disease, bird flu testing

By Liz Carey

Clinical laboratories incentivized to develop diagnostic tests earlier.

September 17, 2024

Multiregional clinical trial data on FDA watch for U.S. applicability

By LabPulse.com staff writers

Pivotal trials drawing on foreign clinical data in focus.

September 16, 2024

Previous Page

Page 2 of 191

Next Page